In our debut episode of The Bean Pod, host Dr. Amirtha Chinnadurai sits down with Dr. Keia Sanderson (Children’s National Hospital) to discuss best practices for prenatal counseling in congenital anomalies of the kidney and urinary tract (CAKUT).Together, they explore how pediatric nephrologists can support families with clarity, compassion, and practical guidance during these high-stakes conversations. Key takeaways: What must be included in every prenatal consult Strategies for discussing

Listen to 127 Future Now Show DolphinsIn the first hour were lucky to get both Ed Ellsworth and Tanmayo Brown as our guests this week, as they prepare to host their Dolphin Yoga Retreat next week on the Big Island of Hawaii. Both are seasoned explorers of dolphin and whale communications and will be offering a 6 day interspecies experience at the famous Point House in the storied Kealakekua Bayon the Kona coast of the island of Hawaiʻi. They share with us some of the magic that happens in their

Host: Marwan Sabbagh, MD, FAAN Guest: Alireza Atri, MD, PhD Guest: Christoph U. Correll, MD Neuropsychiatric symptoms (NPS) associated with Alzheimer’s disease (AD), such as psychosis and agitation, affect up to 50% of individuals with AD yet remain underdiagnosed and undertreated in clinical practice. These symptoms accelerate cognitive decline, increase mortality risk, and substantially worsen patient and caregiver quality of life. This broadcast replay will provide a

What Makes Leadership Truly Ethical?

Guest: Jennifer Caudle, DO Host: Patrick McGill, MD Current cancer screening guidelines cover just five cancers—breast, lung, colon, prostate, and cervical—leaving many aggressive cancers undetected until later stages. But multi-cancer early detection (MCED) testing is reshaping the landscape with blood-based analyses of cell-free DNA and methylation patterns to identify potential cancers earlier than traditional imaging. Designed for the general population over age 50, MCED

CME credits: 0.25 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/resectable-head-neck-cancer-a-team-based-approach-to-perioperative-immunotherapy/35705/ Join our expert panel as they explore the evolving treatment landscape of resectable locally advanced head and neck squamous cell carcinoma. Learn how perioperative immune checkpoint inhibitors are improving event-free survival and get practical insights on applying this data to clinical care. The

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-evolving-landscape-of-resectable-locally-advanced-hnscc/36576/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/rationale-for-combining-radiation-and-immunotherapy-in-resectable-locally-advanced-hnscc/36592/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/emerging-evidence-for-perioperative-icis-in-locally-advanced-hnscc/36593/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/risk-stratification-and-patient-selection-for-perioperative-icis/36633/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/applying-perioperative-icis-in-clinical-practice/36634/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven investigation

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/managing-immune-related-adverse-events-in-the-perioperative-setting/36635/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have

CME credits: 0.75 Valid until: 22-08-2026 Claim your CME credit at https://reachmd.com/programs/cme/multidisciplinary-collaboration-facilitates-multimodality-therapy/36636/ This online CME activity examines advances in managing resectable locally advanced head and neck squamous cell carcinoma (HNSCC), focusing on the integration of perioperative immune checkpoint inhibitors (ICIs) and multimodal approaches. Faculty review current standards of care and highlight unmet needs that have driven

Sydney Adams, a CDC ORISE fellow, and Dr. Johanna Salzer, a veterinary medical officer and epidemiology team lead in CDC's Division of Vector-Borne Deases, discuss national surveillance of human ehrlichiosis caused by Ehrlichia ewingii in the United States.

In this episode, Daisy, Laura and Olivia talk about some Vs in the history of medicine: virgins, vampirism and vaccines. _______________ Follow us on: Bluesky - @physiciansgallery Instagram - @physiciansgallery TikTok - @physiciansgallery Facebook - www.facebook.com/PhysiciansGallery Sign up for our newsletter - www.rcpe.ac.uk/newsletter To support heritage at the RCPE, please donate: www.rcpe.ac.uk/donate _______________ The Team: Olivia Howarth (@oh_archives) - Researcher/Presenter Dr

Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions.

Welcome to the Prehospital Emergency Care Journal Podcast! Today, we're tackling a critical and often deadly emergency seen at mass gatherings like music festivals: psychostimulant-induced hyperthermia (PIH). This condition carries high mortality rates, but what if early, aggressive intervention could dramatically improve outcomes? Join us as we discuss the paper, "Physician Directed Prehospital Treatment in Psychostimulant Induced Hyperthermia: A Case Series," with one of its lead authors, Dr

In this podcast, George M. Ibrahim & Carolina Gorodetsky discuss their paper 'Deep brain stimulation for neurological and neurodevelopmental disorders in children: Current applications and future perspectives'.The paper is available here: https://doi.org/10.1111/dmcn.16452 Follow DMCN on Podbean for more: https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of

Host: Jonathan Barratt, MD, PhD Faculty: Sydney Tang, MBBS, MD In this episode of Clinical Countdown, Professors Jonathan Barratt and Sydney Tang discuss the evolving treatment strategies for IgA nephropathy, focusing on lowering proteinuria through combination therapy. They examine differences in disease presentation across global populations and emphasize updated KDIGO guidance on aggressive proteinuria reduction targets. The discussion includes evidence from the PROTECT trial

In this webinar, you will learn how to use QIAGEN Ingenuity Pathway Analysis to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types.Explore:• How to analyze miRNA-seq datasets alone or together with the corresponding mRNA datasets• How to use QIAGEN IPA without a dataset, using miRNA IDs• An introduction to databases and curated content specific to miRNA• How to effectively apply various filters and